Skip to content

Clinical study on the key technologies and specific mechanisms of transcranial magnetic regulation at DLPFC and rTPJ region to improve the core symptoms and comorbidities of autism spectrum disorder

Clinical study on the key technologies and specific mechanisms of transcranial magnetic regulation at DLPFC and rTPJ region to improve the core symptoms and comorbidities of autism spectrum disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071707
Enrollment
Unknown
Registered
2023-05-23
Start date
2023-05-25
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

Observation group 1:1Hz-rTMS stimulates right DLPFC
Observation group 2:10Hz-rTMS stimulates rTPJ
Observation group 3:10Hz-rTMS stimulates rTPJ
Control group:Pseudo-stimuli

Sponsors

Xuzhou Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Age at enrollment: 3-6 years old, Han children; 2. Meet the diagnostic criteria for ASD in the revised fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), as last revised on 18 March 2022; 3. The parents of the child agree and sign the informed consent form, and can cooperate with the treatment; 4. Complete clinical data; 5. Wechsler Intelligence Test >= 70 points; 6. Autism Interview Scale (CARS) >= 32 points; 7. Overall score from the Children's Sleep Habits Questionnaire (CSHQ) baseline > 41; 8. Impaired executive function: Preschool children's BREIF-P T score >= 65; 9. Right-handed; 10. No medication was taken during the study.

Exclusion criteria

Exclusion criteria: 1. Metal or electronic instruments near the irritation site of the coil; 2. History of epilepsy; 3. History of brain trauma, brain tumor, or other disease; 4. Have a serious heart condition or other major physical condition; 5. Diagnosis of other psychiatric disorders (e.g., attention deficit hyperactivity disorder, schizophrenia, and depression); 6. Other neurodevelopmental disorders, inherited metabolic diseases, or severe neurological disorders; 7. Previous treatment for TMS; 8. Serious incomplete case data; 9. Those who do not cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Children's Sleep Habits Questionnaire (CSHQ);Autism Treatment Evaluation Checklist (ATEC);Behavior Rating Scale of Executive Function Preschool Version (BREIF-P);

Secondary

MeasureTime frame
Resting EEG assessment;Image data;

Countries

China

Contacts

Public ContactAizhen Qiu

Xuzhou Children's Hospital

13775997106@163.com+86 189 5217 3603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026